|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| ANTIBACTERIAL & ANTIFUNGAL DRUG DISCOVERY & DEVELOPMENT SUMMIT | ||||||||||||||||
| May 16, 2001 | ||||||||||||||||
|
Strategic Research Institute, Renaissance Amsterdam Hotel, Amsterdam EUROPE June 28-29, 2001 SECTIONS: Antibiotic Discovery Strategies & New Targets Antibacterial Resistance Studies & Prevalence Antibacterial Clinical Compounds New Anti-Fungal Agents & Clinical CompoundsANTIBACTERIAL KEYNOTE: The Trouble With Gram-Negatives David M Livermore, Ph.D CENTRAL PUBLIC HEALTH LABORATORY ANTIFUNGAL KEYNOTE & SECTION: New Anti-Fungal Agents: Filling a Clinical Need Frank C. Odds, Ph.D., FRCPath UNIVERSITY OF ABERDEEN FEATURING: MERCK(Cancidas) FUJISAWA(Micafungin) SCHERING-PLOUGH(Posaconazole) |
||||||||||||||||
| Organized by: | Strategic Research Institute | |||||||||||||||
| Invited Speakers: | PRESENTERS INCLUDE: Eli Lilly Company Procter & Gamble Pharmaceuticals Institut Pasteur Wyeth Ayerst Research GlaxoSmithKline The R.W. Johnson PRI Cubist, Inc. Ribotargets |
|||||||||||||||
| Deadline for Abstracts: | ALL SLOTS ARE FULL | |||||||||||||||
| Registration: | Contact Mark Alexay, 212-967-0095 x251 or Email Malexay@srinstitute.com for show information/reg | |||||||||||||||
| E-mail: | malexay@srinstitute.com | |||||||||||||||
| Posted by: | Mark Alexay | |||||||||||||||
| Host: | 12.3.58.10 | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||